HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...
This year’s Conference on Retroviruses and Opportunistic Infections (CROI) features several sessions discussing prevention ...
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...
Health on MSN6d
Signs and Symptoms of Thrush (Oral Candidiasis)Medically reviewed by Edmund Khoo, DDS Thrush, or oral candidiasis, is a fungal infection in your mouth and throat. It is ...
The World Health Organization (WHO) insisted as the March 24 Tuberculosis (TB) Day looms over that the disease remains one of ...
To learn more, please visit www.reprievetrial.org.
Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.
Bacterial vaginosis affects nearly 1 in 3 women of reproductive age. A study adds to evidence it is sexually transmitted, ...
Incyte said on Monday its experimental drug has met the main goal in two separate late-stage studies testing it in patients with an inflammatory skin condition called hidradenitis suppurativa.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback